eliminated the latter response. Blocking the phosphatidylinositol 3-kinase (PI3K)-Akt/protein kinase B (PKB) pathway abolished COinduced NO production. Pretreatment with an NOS inhibitor, NO scavenger, or soluble guanylate cyclase inhibitor, did not affect the CO-induced [Ca 2ϩ ]i increase, indicating that NO, soluble guanylate cyclase, and cyclic guanosine 5=-monophosphate are not involved in the CO-induced [Ca 2ϩ ]i increase. CO inhibited the secretory responses to CCK-octapeptide or carbachol. We conclude that CO acts as a regulator not only for [Ca 2ϩ ]i homeostasis via a PLC-IP3-IP3 receptor cascade but also for NO production via the calmodulin and PI3K-Akt/PKB pathway, and both CO and NO interact. Moreover, CO may provide potential therapy to ameliorate acute pancreatitis by inhibiting amylase secretion.
]i). A heme oxygenase (HO) inducer increased [Ca 2ϩ ]i in a concentrationdependent manner, and the increase was diminished by an HO inhibitor. The CO-induced [Ca 2ϩ ]i increase persisted in the absence of extracellular Ca 2ϩ , indicating that Ca 2ϩ release is the initial source for the increase. The inhibition of G protein, phospholipase C (PLC), and inositol 1,4,5-trisphosphate (IP3) receptor diminished the COinduced [Ca 2ϩ ]i increase. CO upregulated endothelial nitric oxide synthase (eNOS) expression and stimulated NO production, and NOS inhibitor, calmodulin inhibitor, or the absence of extracellular Ca 2ϩ eliminated the latter response. Blocking the phosphatidylinositol 3-kinase (PI3K)-Akt/protein kinase B (PKB) pathway abolished COinduced NO production. Pretreatment with an NOS inhibitor, NO scavenger, or soluble guanylate cyclase inhibitor, did not affect the CO-induced [Ca 2ϩ ]i increase, indicating that NO, soluble guanylate cyclase, and cyclic guanosine 5=-monophosphate are not involved in the CO-induced [Ca 2ϩ ]i increase. CO inhibited the secretory responses to CCK-octapeptide or carbachol. We conclude that CO acts as a regulator not only for [Ca 2ϩ ]i homeostasis via a PLC-IP3-IP3 receptor cascade but also for NO production via the calmodulin and PI3K-Akt/PKB pathway, and both CO and NO interact. Moreover, CO may provide potential therapy to ameliorate acute pancreatitis by inhibiting amylase secretion. carbon monoxide; Ca 2ϩ ; nitric oxide; pancreatic acinar cells CARBON MONOXIDE (CO) IS GAINING general acceptance as a potential modulatory molecule in a broad spectrum of biological phenomena including vasodilation, neuromodulation, antiinflammation, antiapoptosis, and antiproliferation. CO is generated by three identified isoforms of heme oxygenase (HO-1, HO-2, and HO-3) in the presence of O 2 and NADPH via the degradation of heme, which releases biliverdin/bilirubin, CO, and free iron/ferritin. Like an inducible nitric oxide synthase (iNOS), various stimuli such as hormones, oxidative stressors, growth factors, and others (30, 39) induce the expression of HO-1, also known as a heat shock protein 32. Its expression is also induced in various disease states (9) . HO-2 is a constitutive enzyme expressed in the brain, testes, cardiovascular system, retina, liver, and gastrointestinal tract (39) . The inducer of HO-2 is limited; adrenal glucocorticoids (61) , opiates (36) , and estrogen (57) can upregulate HO-2 expression, and the enzyme is activated by Ca 2ϩ /calmodulin (CaM) (3) . HO-3 is also a constitutive isoform expressed in the liver, spleen, brain, and kidney of rats but its function is thought to be restricted to heme sensing or heme binding rather than heme degradation (11) .
In the pancreas, previous studies demonstrated that HO-1 expression was not detected in normal islets isolated from rats (67) and mice, but identified in ob/ob mice (38) . HO-1 was found to be induced in ␤ cells (53) or whole islets (24) . Conversely, HO-2 was found to be expressed in islet endocrine cells (25, 38) . In the exocrine pancreas, neither HO-1 nor HO-2 was detected in normal rats (25, 50) , but caerulein-induced acute inflammatory pancreatitis in rats (50) or mice (13) was found to be accompanied by a significant increase in expression of HO-1 in pancreatic tissue.
CO can affect multitudinous sites of cell signaling pathways and preferentially targets heme-containing enzymes. For instance, soluble guanylate cyclase (sGC) is activated to enhance cyclic guanosine 5=-monophosphate (cGMP) production, which plays essential roles as an intermediate in various biological phenomena such as vascular tone regulation, platelet aggregation, reduction of ischemia-reperfusion injury in the lung, and protection of pancreatic ␤ cells from apoptosis (5, 15, 20, 58) . However, the efficacy of CO to activate sGC is reportedly lower than that of nitric oxide (NO) (52) , casting doubt on its physiological roles (30) . The activation of sGC by CO becomes evident when the intracellular levels of NO are low (47) or in the presence of an enhancer such as YC-1 (51). Other molecular targets for CO have been demonstrated, including a Ca 2ϩ -activated large conductance K ϩ (BK Ca ) channel in vascular smooth muscle cells (60, 63) , p38 mitogen-activated protein kinase in response to stress and inflammation (30) , and a serine-threonine kinase/protein kinase B (Akt/PKB) in rat endothelial cells (68) , isolated rat or mouse cardiomyocytes (14, 54) , and rat hepatocytes (31) . CO shows a dual effect on L-type Ca 2ϩ channels in human intestinal smooth muscle [i.e., inhibition or potentiation of the channel activity, (37) ]. CO has been reported to reduce the intracellular Ca 2ϩ signal in human platelets partially via inhibition of capacitative Ca 2ϩ entry (17) . Like CO, Ca 2ϩ is a pleiotropic molecule involved in a wide variety of cellular functions from physiology to pathology. Although Ca 2ϩ plays important roles in the physiology and pathology of pancreatic acinar cells, neither the role of exogenous CO nor the role of endogenous CO has been studied with regard to intracellular Ca 2ϩ homeostasis.
Thus the present study was designed to examine the effects of CO on intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and to define potential action sites of HO/CO in the Ca 2ϩ -associated cell signaling pathway and to define the putative interplay between the CO and NO pathways in pancreatic acinar cells.
MATERIALS AND METHODS
Solutions. HEPES-buffered standard solution used throughout the acinar isolation and experimentation contained the following (in mM): NaCl 138.0, KCl 4.7, CaCl 2 1.3, MgCl2 1.13, Na2HPO4 1.0, D-glucose 5.5, and HEPES 10.0 supplemented with MEM plus 2 mM L-glutamine and 1 mg/ml BSA. The pH was adjusted to 7.4 with NaOH. A nominally Ca 2ϩ -free solution was prepared without the addition of CaCl2 but with the addition of 1 mM EGTA.
Experimental animals, isolation and perfusion of pancreatic acini. All experiments conformed to the guidelines on the ethical use of animals set by the U.S. National Institutes of Health and were approved by the Animal Care and Use Committee of the Graduate School of Veterinary Medicine, Hokkaido University. All efforts were made to minimize animal suffering and to reduce the number of animals used. Male SPF Wistar rats (200 -250 g) were obtained from Clea Japan (Tokyo, Japan) and were housed in a controlled environment at an ambient temperature of 22°C with a 12-h:12-h light-dark cycle. The animals were deprived of food overnight prior to the experiment but were allowed free access to water.
The animals were anesthetized by CO 2 inhalation and euthanized by exsanguination. Freshly isolated pancreatic acini were prepared according to a previously reported method (42, 43) . In brief, the pancreata were excised, freed from fat and lymph nodes, and injected with 5 ml of HEPES-buffered standard solution containing 60 -75 U/ml of collagenase supplemented with 0.1 mg/ml of soybean trypsin inhibitor. The tissue was then incubated in a conical flask at 37°C under vigorous shaking for a total of 30 min. The collagenase was replaced with 5 ml of new collagenase solution and incubated for an additional 30 min followed by mechanical disruption by gentle suction through pipettes with decreasing orificial size. The tissue suspension was then filtered through 150-m nylon mesh, washed three times, pelleted (60 g), and resuspended in a suitable amount of the standard solution. The acinar cell viability was assessed by the trypan blue exclusion test and found to be nearly 100%. For immunohistochemistry, rats were injected with hemin (50 mg/kg ip) and the excised pancreata were employed for immunohistochemical observation as described below.
Confocal imaging of Ca 2ϩ and NO. To detect temporal changes in the intracellular Ca 2ϩ and NO levels, an imaging system was used as previously reported (42, 43) . Briefly, isolated acini were loaded with final concentrations of 10 M Fluo-3/AM or 10 M 4,5-diaminofluorescein diacetate (DAF-2/DA) in the standard solution with mild shaking in the dark for 60 min at 37°C. The acini were then rinsed and transferred to a recording chamber to the bottom of which a Cell-Takcoated cover glass was attached. The chamber was placed on the stage of an inverted microscope (IX; Olympus, Tokyo, Japan) of a laser scanning confocal imaging system (LSM FV500; Olympus). The probe-loaded acini in the recording chamber were perfused with the standard solution at a flow rate of 1 ml/min before and throughout the experiments. The acini were illuminated at 488 nm with a krypton/argon laser, and the emission light (Ͼ505 nm) was guided through a ϫ40 water immersion objective to a pinhole diaphragm. Photodamage was minimized by attenuating the laser intensity with a neutral density filter interposed into the illumination path (1% transmission was sufficient to obtain fluorescence). Confocal images of Fluo-3 or triazolofluorescein (DAF-2T) fluorescence were recorded at 10-s intervals. The time courses of changes in fluorescence intensity (F.I.) at regions of interest (ROI) were analyzed using bundled software (Fluoview 5.0 with Tiempo; Olympus). Analyses were conducted by averaging the F.I. changes in all the cells constructing an acinus. The change in the fluorescence intensity was calculated as the percent of basal fluorescence intensity by setting the prestimulated fluorescence prior to the application of drugs at 100% (baseline) (F/F o ϫ 100). The changes in [Ca 2ϩ ]i and NO production were estimated by calculating the summed area of fluorescence changes (SFC) above the baseline during treatment or stimulation (42, 43) . All experiments for the measurement of [Ca 2ϩ ]i and NO were performed at room temperature, and isolated acini were used for experiments within 4 h of isolation.
Immunohistochemical analysis of endothelial NOS. Immunohistochemical detection of endothelial NOS (eNOS) was conducted as reported previously (48) . In brief, paraffin sections (3 m in thickness) from the pancreatic tissues originally fixed in buffered formalin were deparaffinized, rehydrated, and heated in citrate buffer (pH 6.0) for 20 min. After endogenous peroxidase activity was blocked, sections were rinsed, preincubated with 5% normal goat serum, and incubated overnight at 4°C with a primary antibody against eNOS (rabbit polyclonal, 1:200; Santa Cruz Biotechnology, Santa Cruz, CA). The sections were then treated with a biotinylated secondary antibody, goat anti-rabbit IgG (Sigma, St. Louis, MO), for 30 min at 37°C followed by incubation with streptavidin peroxidase (1:100) for 1 h. Finally, all the sections were treated with diaminobenzidine reagent for color development and counterstained with hematoxylin. The number of immunoreactive cells was counted under a light microscope and the percentage was calculated. In addition, the immunofluorescence analysis for eNOS expression was also conducted with Alexa Fluor 488 anti-rabbit IgG (1:200; Invitrogen, Waltham, MA) followed by Hoechst 33342 (Dojindo, Kumamoto, Japan). Intracellular localization of eNOS was examined via fluorescence microscopy (BZ-9000; BIOREVO). As a negative control, the sections were incubated without the primary antibody.
Amylase measurement. To assess the pancreatic secretory responses, the amount of amylase released into the incubation medium was measured using a method previously reported (21) with some modifications. Briefly, isolated acini suspensions in a group of conical flasks were stimulated with increasing concentrations of carbon monoxide-releasing molecule-2 (CORM-2) alone, or CCK-octapeptide (CCK-8) or carbachol (CCh) in the absence and presence of 0.5 mM CORM-2 for 30 min at 37°C with gentle shaking. At the end of a 30-min incubation period, 1-ml aliquots of acini suspension were pelleted and the supernatants were removed and held on ice. The amylase activity was determined in duplicate for each supernatant using colorimetric assay kits (AMYL-P; Fuji Film, Tokyo, Japan) with an automatic analyzer (Dri-Chem 7000; Fuji Film Medical, Tokyo, Japan). The amylase released during the 30-min incubation period was expressed as a percentage of the total amount of enzyme initially present in the acinar cells.
Chemicals. Chromatographically purified collagenase (CLSPA) was obtained from Worthington Biochemical (Lakewood, NJ). Fluo-3/AM, EGTA, NG-monomethyl L-arginine (L-NMMA), HEPES, and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO) were obtained from Dojindo (Kumamoto, Japan). MEM was purchased from Invitrogen (Carlsbad, CA). DAF-2/DA was purchased from Daiichikagaku (Tokyo, Japan). Statistical analysis. The reported values are means Ϯ SE. Statistical significances were determined using one-way ANOVA and un-paired Student's t-tests depending on the number of groups for comparison (http://www.physics.csbsju.edu/stats/); P Ͻ 0.05 was considered significant.
RESULTS

Effect of CO on [Ca 2ϩ
] i in pancreatic acinar cells. The effects of CO on [Ca 2ϩ ] i were examined using a CO donor, CORM-2, from which CO is released spontaneously, mimicking the biological actions of CO. Fig. 1 shows typical time courses of [Ca 2ϩ ] i changes induced by CORM-2 at concentrations ranging from 0.1 to 1 mM. The [Ca 2ϩ ] i changes were found to be dose-dependent; the [Ca 2ϩ ] i increase was gradual at the lowest concentration, oscillatory at medium concentrations, and monophasic at the highest concentration (Fig. 1, A-E) (P Ͻ 0.001 by ANOVA). The dose-dependent manner of CORM-2-induced [Ca 2ϩ ] i changes was analogous to changes recorded in acini when stimulated with physiological secretagogues such as CCK-8 or ACh (22) . The maximal [Ca 2ϩ ] i response was obtained at 0.5 mM (186%, Fig. 1E ). The EC 50 of the increasing phase was calculated to be 287 M. Fig. 1F shows that 0.5 mM CORM-2-induced temporal and spatial [Ca 2ϩ ] i dynamics with pseudocolors, the time course of which is described in Fig. 1C .
To investigate the potential involvement of intrinsic HO, hemin, a substrate of HO-1, was applied. Hemin at concentrations ranging from 0.01 to 0.5 mM caused a dose-dependent increase in [Ca 2ϩ ] i (Fig. 2, A ] i . The hemin-induced increase at 0.1 mM was partially but significantly inhibited by the HO inhibitor ZnPPIX (P Ͻ 0.05 by Student's t-test). The increment from the unstimulated value was diminished by 33% (Fig. 2C) (Fig. 4A) . The increment was significantly reduced by 33% (Fig. 4B, P Ͻ 0.05 ] i increase was partly triggered by the PLC/IP 3 pathway. Third, to further test the possible involvement of the G q protein in PLC/IP 3 pathway initiated by CO, the effect of GP2A, a G q protein inhibitor, was examined. Figure 4C shows the inhibitory effect of 10 M GP2A in the absence of extracellular Ca 2ϩ . The SFC was decreased by 30% ( Fig. 4D, P intracellular enzymes such as sGC, NOS, and cytochrome-c oxidase, which contain a heme domain in their molecular structures. The possible production of intracellular NO by CO was investigated using a fluorescent NO probe, DAF-2/DAF-2T. We found that increasing the concentrations of CORM-2 (0.1 to 1 mM) induced gradual and continual NO production in the presence of extracellular Ca 2ϩ (Fig. 5A) . The CO-induced NO production was dose-dependent ( Fig. 5B , P Ͻ 0.001 by ANOVA). The EC 50 was calculated to be 277 M, which is nearly equal to that of the CO-induced [Ca 2ϩ ] i increase (287 M as stated before). Moreover, increasing concentrations of an HO-1 inducer, hemin (10 -500 M), could stimulate NO production, although some decrease in the increment was found at a higher concentration (Fig. 5C , P Ͻ 0.001 by ANOVA). The immunohistochemical and immunofluorescence analyses showed the baseline expression of eNOS in the nuclei of acinar, centroacinar, and intercalated ductal cells, in addition to vascular endothelial cells (Fig. 5E) . Interestingly, the percentage of immunopositive nuclei was increased by hemin treatment (54.2 Ϯ 1.06%) compared with the control without hemin (34.6 Ϯ 3.3%, Fig. 5D , P Ͻ 0.001). Taken together, these findings suggest that CO stimulates NO production via eNOS localized in the acinar cells.
An attempt was made to explore the mechanism of NO production by CO. NO production induced by CORM-2 at 0.1 mM was significantly diminished by the removal of extracellular Ca 2ϩ , a NOS inhibitor, L-NMMA (100 M), or by a CaM antagonist, SKF-7171A (10 M). The increment of SFC from the unstimulated value was diminished by 43%, 37%, and 61%, respectively ( Fig. 6 , P Ͻ 0.001), suggesting the involvement of intracellular Ca 2ϩ and CaM in CO-induced NOS activation, which leads to NO production. Next, we attempted to assess whether the phosphoinositide 3-kinase (PI3K)-Akt/PKB signaling pathway is involved in NOS activation and resultant NO production by CORM-2. Both a PI3K inhibitor, LY29004 (20 M), and an Akt/PKB inhibitor, SH-5 (10 M), significantly decreased NO production induced by 0.1 mM CORM-2 (Fig. 6A) . The increment of SFC was attenuated by 62% and 34%, respectively ( Fig.  6B , P Ͻ 0.001). The results indicated that CO activates PI3K, which in turn activates Akt/PKB and enhances NO production, likely via eNOS activation. To assess the possible involvement of reactive oxygen species (ROS) in CO-induced NO production, a cell-permeable superoxide dismutase mimetic and peroxynitrite scavenger, Mn-TBAP (50 M), was applied. As shown in Fig. 6 , the pretreatment with the ROS scavenger did not affect CORM-2-induced NO production. However, hemin-induced NO production was partially attenuated in the presence of Mn-TBAP (Fig.  6C , P Ͻ 0.01). CO-induced NO production, the effects of a nonspecific inhibitor of all NOS isoforms, L-NMMA, and an NO scavenger, cPTIO, were examined. The CORM-2-induced [Ca 2ϩ ] i increase was found to be unaffected by treatment with 100 M L-NMMA or 300 M cPTIO (Fig. 7, A and B) . Moreover, 100 M and 300 M ODQ, a specific sGC inhibitor, also did not affect the [Ca 2ϩ ] i increase induced by 0.1 mM CORM-2 (Fig.  8, A and B) . Taken together, these findings imply that NO and the resultant sGC activation are not attributable to the CORM-2-induced [Ca 2ϩ ] i increase in pancreatic acinar cells. Effect of CO on secretagogue-induced amylase release. The effects of CO alone or those on the CCK-8-or CCh-induced amylase release from pancreatic acini were studied. The doseresponse curve for amylase release by CORM-2 was found to be bell-shaped; significant increases in amylase release (53% increment from the basal) at a medium concentration (0.5 mM) followed by a significant decrease (71% reduction from the basal) at a higher concentration (1 mM) were observed ( Fig. 9A , P Ͻ 0.01). When acini were stimulated with increasing concentrations of CCK-8 or CCh in the presence of 0.5 mM CORM-2, the dose-response curve obtained for each secretagogue alone was shifted downward, indicating that CO significantly inhibited the secretagogue-induced secretory response (Fig. 9, B and C) . dose-dependently (0.1 to 1 mM) increases [Ca 2ϩ ] i in the exocrine pancreas. The increase was gradual at lower concentrations (0.1-0.3 mM), oscillatory at moderate concentrations (0.4 -0.5 mM), and monophasic at a higher concentration (1 mM) of CORM-2 ( Fig. 1) , which appeared to be analogous to what we usually observe in acinar cells stimulated with physiological secretagogues such as CCK-8 (22 ] i was reduced in cerebral arteriole smooth muscle cells of piglet (64) , leading to dilation in smooth muscles. Gende (17) also revealed that multiple agonist-induced [Ca 2ϩ ] i increases in human platelets were attenuated in a solution bubbled with CO, partially via the inhibition of capacitative Ca 2ϩ entry. The promotion of the appearance of Ca 2ϩ transients and synchronization by hemin was described in glucosetreated pancreatic ␤ cells, (38) . Thus the effect of CO is variable depending on tissues.
Effect of NOS inhibitor, NO scavenger, and sGC inhibitor on CO-induced [Ca
The current finding that hemin caused a concentrationdependent increase in [Ca 2ϩ ] i and that this increase was diminished by a hemin inhibitor, ZnPPIX (Fig. 2) supports an idea that endogenous CO triggers [Ca 2ϩ ] i elevation in pancreatic acinar cells. In the exocrine pancreas, multiple conditions such as oxidative stress and an overdose application of caerulein (13, 50) reportedly induce HO-1, and the resultant production of CO is thought to be a key factor that serves to ameliorate inflammatory insult. In conjunction with this mechanism, hemin can offer a therapeutic approach to prevent acute pancreatitis via the upregulation of HO-1 (44) . Collectively, the current findings suggested the involvement of exogenously and endogenously produced CO in the regulation of [Ca 2ϩ ] i in pancreatic acinar cells.
The source of Ca 2ϩ for CO-induced [Ca 2ϩ ] i was found to be mostly intracellular at low and moderate concentrations of CORM-2; extracellular Ca 2ϩ is also attributable at a 0.5 mM concentration (Fig. 3) . We examined how CO could induce the release of intracellularly stored Ca 2ϩ . Pharmacological scru- tiny using various inhibitors indicated that each G q protein, PLC, IP 3 , and IP 3 R pathway takes part in the CO-induced [Ca 2ϩ ] i release in pancreatic acinar cells (Fig. 4) . This cascade is mostly identical to the Ca 2ϩ -releasing mechanism proposed in our previous papers for two other gaseous messengers, NO and H 2 S (42, 43). Inverse results have been reported in other tissues; in an in vivo study, an HO-1 inducer, hemin, suppressed PLC activity, attenuated IP 3 , and reduced the resting [Ca 2ϩ ] i in the aorta and left ventricle of spontaneously hypertensive rats with high aldosterone levels (45, 46) . It seems contradictory, but the apparent discrepancy can be interpreted by the fact that aldosterone stimulates PLC (6) and hemin inhibits aldosterone level in vivo (45, 46 ). Thus at the cellular level, hemin can activate PLC-IP 3 -Ca 2ϩ release via the production of CO, as was found in the present study.
CO stimulates production of NO. Understanding the crosstalk between CO and NO, or even including H 2 S, draws attention to the physiological and/or pathophysiological effects of these gases (8, 42, 62) . The cellular physiology of CO is complex, and CO can modulate NO production in multiple ways. CO may activate NOS and NO production or may induce NO release from a storage pool but suppress NOS (55) . It was also revealed that high levels of CO inhibit NOS activity and NO generation, whereas lower concentrations induce the release of NO, which is most likely a preexisting intracellular heme-bound pool of NO, rather than a direct stimulation of eNOS (55) . Hemin has been reported to inhibit glucoseinduced NO production in pancreatic islets, suggesting COinduced NOS inhibition (24, 25) . On the contrary, the activation of eNOS via Akt by CO has been demonstrated, which protected from ischemia-reperfusion injury (14) . Moreover, the activation of L-type Ca 2ϩ channels by CO via NOS-NO production in HEK-293 cells has been described (37) , although the attenuation and quenching of NO production by CORM-2 in aortic smooth muscle cells has been reported, suggesting that CORM-2 inhibits NO-induced signaling and vasorelaxation (40) . Thus the effect of CO on NO production has been regarded as two-sided (47) . The dose-dependent NO production by CORM-2 and hemin was demonstrated in the present study (Fig. 5, A-C) . Moreover, we found that the eNOS immunoreactivity was present in the cell nucleus of not only acinar but also centroacinar, intercalated ductal cells and endothelial cells, and that eNOS expression was further enhanced by hemin treatment (Fig. 5, D and E) , leading us to conclude that NO is produced in pancreatic acinar cells when eNOS is activated by various factors such as CORM-2 and hemin. Western blot analysis revealed the expression of eNOS in the whole pancreas as well as pancreatic acinar cell lysates (2) and, reportedly, ϳ30% of whole eNOS protein was expressed in pancreatic acinar cells (10) . In addition, the nucleus-localized eNOS expression was implied in various cell types (16, 18, 19, 33). Hemin-induced eNOS gene expression was reported in endothelial progenitor cells (59) . Taken together, it is highly possible that CORM-2 and hemin upregulate eNOS expression, resulting in NO production in pancreatic acinar cells.
Regarding the mechanisms by which CO stimulates NO production, the interaction between the CO/Akt pathway (29, 68) and activation of the PI3K-Akt/PKB-NOS pathway (35) and the Akt/PKB-eNOS pathway (14) by CO have been proposed. Pharmacological experiments conducted in the present study showed that NO production depended on the dose of the CO donor, the presence of extracellular Ca 2ϩ , activation of NOS and CaM, production of PI3K, and upregulation of Akt/PKB. On the basis of these results and previous reports, it was presumed that in addition to Ca 2ϩ /CaM-mediated NOS activation and resultant NO production, a PI3K-Akt/PKB signaling pathway is involved in CO-induced NO production in pancreatic acinar cells (Fig. 6) .
ROS and NO have been implicated in mediating not only physiological signaling responses but also pathophysiological causal effects. It has been reported that NO formation and the bioavailability could be impaired by ROS (41) and that Ca 2ϩ may act both upstream and downstream of ROS and NO production (66) . These complicated interactions make it difficult to understand the intracellular cascade triggered by the gaseous molecules. We found that the scavenger of peroxynitrite and superoxide, Mn-TBAP, had no appreciable effect on CORM-2-induced NO production but it partially inhibited hemin-induced NO production (Fig. 6C) , indicating that ROS are not involved in the former but are partly attributable to the latter. Although a clear interpretation for the potential involvement of ROS in the hemin-induced NO production waits for further experimentation, it is speculated that hemin degradation products such as free iron but not CO are at least in part involved in hemin-induced NO production due to its ROSgenerating catalyzing action (56) .
Is NO and sGC activation involved in CO-induced [Ca 2ϩ ] i increase? We recently hypothesized that NO itself and H 2 S could induce [Ca 2ϩ ] i via an increase in NO production due to the activation of sGC (42, 43) . However, despite the significant increase in NO by CO possibly via activation of NOS (Fig. 5) , the present study did not support the positive involvement of NO in CO-induced [Ca 2ϩ ] i increases because both NOS inhibitor and NO scavenger did not affect [Ca 2ϩ ] i increases (Fig. 7 ). The precise reason for this is unclear, but we presume that the amount of NO produced by CO is not sufficient to trigger [Ca 2ϩ ] i dynamics. Alternatively, CO may rather diminish Ca 2ϩ entry after the depletion of the Ca 2ϩ pool, possibly via inhibition of cytochrome P450 (CYP450) (1, 4, 17, 49) , as discussed below. Neither sGC nor cGMP was demonstrated to be involved in CO-induced [Ca 2ϩ ] i increase in the present study (Figs. 7 and 8 ). Like NO, CO has been reported to have the potential to activate sGC because sGC is a heme-containing enzymes (62) . Compared with NO, CO can reportedly only weekly activate sGC; NO could enhance sGC activity by a factor of 130, but CO resulted in only a 4.4-fold increase (52) . A fourfold activation has also been reported (28) . Christova et al. (7) demonstrated that CO can inhibit platelet aggregation and relax blood vessels by activating sGC and elevating the intracellular level of cGMP. Conversely, a significant increase in cGMP level due to CO has not been reported in other tissues (12, 32) . Even attenuation of NO-induced sGC activation by CO has been demonstrated in cerebellar granule cells (26) . The final biological effect of CO has been suggested to depend on various factors such as the amount of CO, the amount of endogenously produced NO, and the concentration of CO that can react with NO (40) . Moreover, when the local concentration of NO is low, CO could modestly activate sGC (27) . These data indicate that CO likely acts as a partial activator of sGC, whereas CO alone is much less effective in activating sGC than NO alone; CO rather inhibits NO-induced sGC activation by competitively acting on sGC molecules. Thus although CO produces a significant amount of NO, the CO released from CORM-2 would mask sGC activation by the produced NO, and CO itself could not significantly activate sGC. Therefore, NO is not related to the CO-induced [Ca 2ϩ ] i increase in pancreatic acinar cells.
CO alone induces faint amylase release but markedly inhibits secretagogue-induced amylase release. CO was found to induce a faint release of amylase but it unexpectedly and markedly inhibited CCK-8-or CCh-induced amylase release (Fig. 9) . In general, a secretory response in pancreatic acinar cells is thought to be triggered when [Ca 2ϩ ] i is increased by mobilization from intracellular stores, entry from the extracellular space, or both. The faint increase in amylase release by CO could be due to an increase in [Ca 2ϩ ] i that is mainly the result of Ca 2ϩ mobilization. We hypothesized that the postprandial long-lasting exocrine secretion is due to a mandatory continuous increase in [Ca 2ϩ ] i , which can be first accomplished by the release of Ca 2ϩ from intracellular stores followed by sustained entry from the extracellular space (23) . In other words, intracellularly stored Ca 2ϩ is attributed to the early stage of secretion, and the presence of extracellular Ca 2ϩ is necessary for the subsequent secretory response. Regarding intracellular Ca 2ϩ dynamics, CO has been reported to inhibit capacitative Ca 2ϩ entry by interfering with and inhibiting CYP450, which accelerates plasma membrane Ca 2ϩ influx triggered after Ca 2ϩ store depletion (1, 4, 17, 49) . Thus inhibition of the secretagogue-induced secretory response by CO is presumably due to the inhibition of CYP450 by CO via a mechanism distal to the Ca 2ϩ mobilizing mechanism but related to the decreased Ca 2ϩ influx in pancreatic acini. Several lines of evidence have demonstrated the protective and therapeutic role of HO-1 and CO in various inflammatory conditions, especially acute pancreatitis. CORM-2 suppressed the levels of systemic inflammatory cytokines, as well as macrophage tumor necrosis factor-␣ secretion, serum amylase, and lipase secretion (65) . However, the mechanism by which CO physiologically or pathophysiologically regulates pancreatic exocrine secretion in the normal and inflammatory pancreas has not yet been elucidated. The above-noted hypothesis has shed light on the therapeutic potentials of CO and/or CYP450 in the amelioration of acute pancreatitis.
In conclusion, the current study has for the first time demonstrated the role of CO in intracellular Ca 2ϩ homeostasis in pancreatic acinar cells that possess the HO/CO system. The system represents a novel regulatory system of physiological and pathophysiological significance for the regulation of [Ca 2ϩ ] i . This pathway is independent of sGC-cGMP, but an unknown signaling factor may act as an intermediate in the CO and G q protein-PLC-IP 3 -IP 3 R pathway. Moreover, a positive interaction between CO and eNOS/NO via the Ca 2ϩ /CaM and PI3K-Akt/PKB system has been suggested, and both gases play a fundamental role in regulating [Ca 2ϩ ] i in pancreatic acinar cells (Fig. 10) .
